Systematic analysis of loss-of-function variants across MODY genes demonstrates gene- and NMD-specific effects and identifies NMD-escape INS variants as a novel cause of MODY

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Aims/hypothesis

Accurate interpretation of loss-of-function (LOF) variants in MODY genes is essential for diagnosis but remains challenging, particularly for variants predicted to escape nonsense-mediated decay (NMD). We aimed to systematically evaluate the pathogenicity of LOF variants, stratified by NMD-triggering and NMD-escape status, across all known MODY genes.

Methods

We analysed ultra-rare LOF variants (minor allele frequency <1 in 10,000) in 5171 individuals of European ancestry with suspected MODY, compared with 155,501 population-based controls from UK Biobank. LOF variants in ABCC8, GCK, HNF1A, HNF4A, HNF1B, INS, KCNJ11, NEUROD1, PDX1 , and RFX6 were classified as NMD-triggering or NMD-escape. We tested for gene-level enrichment in cases versus controls. For novel associations, we performed replication in additional MODY cases, assessed familial co-segregation, and undertook in-silico protein modelling.

Results

LOF variants were significantly enriched in all MODY genes except ABCC8 and KCNJ11 . Both NMD-triggering and NMD-escape variants were enriched in GCK, HNF1A , and HNF4A , consistent with haploinsufficiency (all P <10 -3 ). HNF1B and RFX6 showed enrichment only for NMD-triggering variants, while NEUROD1 and PDX1 were enriched for only NMD-escape variants.

A novel finding was significant enrichment of only NMD-escape LOF variants in INS (OR = 181, P < 10 -5 ). Including replication, we identified eight families with 17 affected individuals carrying INS variants. These variants co-segregated with diabetes (LOD score = 3), included one de novo case, and were absent from >800,000 population controls. Individuals presented with diabetes at a median age of 19 years, had median BMI of 22.9 kg/m 2 , were negative for islet autoantibodies, and had low type 1 diabetes genetic risk scores. Compared with INS missense MODY, diagnosis occurred ∼10 years later. Protein modelling suggested that INS NMD-escape variants produce aberrant proinsulin molecules with unpaired B chain cysteines, leading to milder misfolding.

Conclusions/interpretation

The pathogenicity of LOF variants in MODY genes depends on gene context and NMD status. Heterozygous NMD-escape LOF variants in INS are a novel cause of MODY. These findings provide systematic gene-level evidence to inform variant interpretation guidelines and improve the accuracy of MODY diagnosis in clinical practice.

Research in Context

What is already known about this subject?

  • Interpretation of loss-of-function (LOF) variants is complex and strongly influenced by predicted NMD status.

  • Current evidence for LOF variants in MODY genes is mainly based on case reports.

  • Systematic genetic evidence is needed to improve diagnosis and to inform gene-specific variant interpretation guidelines.

What is the key question?

  • Do NMD-triggering and NMD-escape LOF variants contribute to MODY across all known MODY genes?

What are the new findings?

  • Heterozygous NMD-escape LOF variants in INS are a novel cause of MODY.

  • Heterozygous LOF variants in ABCC8 and KCNJ11 are not enriched in MODY.

  • Enrichment of NMD-triggering and NMD-escape LOF variants differs across MODY genes, clarifying underlying mechanisms and supporting gene-specific interpretation.

How might this impact on clinical practice in the foreseeable future?

  • These results improve the accuracy of MODY diagnosis by providing robust evidence for variant interpretation and supporting gene-specific clinical guidelines.

Article activity feed